PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes |
| September 06, 2012 | September 2012 Bond Updates |
|
INCLINE VILLAGE, Nev., Sept. 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the:
(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)
2.875% Convertible Senior Notes due February 15, 2015... |
| View more at: http://www.prnewswire.com/news-releases/pdl-biopharma-announces-conversion-rate-adjustments-for-convertible-notes-168669486.html |
| Related News |
|